Combined Dupilumab and Allergen-Specific Immunotherapy in Severe Refractory Atopic Dermatitis.

Allergy Asthma Immunol Res · 2024 · PMC11621481 · PMID 39622691

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

10 , 15 Our study also supported this, as patients receiving dupilumab consistently showed a decreasing trend in IgE levels.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.